TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Emyria Ltd ( (AU:EMD) ) has provided an announcement.
Emyria Ltd has announced the quotation of 217,725 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of November 28, 2025. This move is part of the company’s strategy to enhance its financial flexibility and operational capacity, potentially strengthening its position in the healthcare market and offering new opportunities for stakeholders.
The most recent analyst rating on (AU:EMD) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Emyria Ltd stock, see the AU:EMD Stock Forecast page.
More about Emyria Ltd
Emyria Ltd operates in the healthcare industry, focusing on the development and commercialization of innovative medical treatments and technologies. The company is involved in providing advanced healthcare solutions and services, with a market focus on improving patient outcomes through cutting-edge research and development.
Average Trading Volume: 3,551,416
Technical Sentiment Signal: Buy
Current Market Cap: A$40.9M
See more data about EMD stock on TipRanks’ Stock Analysis page.